Pictet Asset Management (Switzerland)’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
AIM
Pictet Asset Management (Switzerland)'s EXAS Position: Q2 2023 in Review
Pictet Asset Management (Switzerland) increased its Exact Sciences (EXAS) stake by 2.5% in Q2 2023, buying an estimated $114K and bringing the position to 61,069 shares worth $5.73M. The position accounts for 0.01% of the portfolio, ranked #743.
Pictet Asset Management (Switzerland) first reported a position in EXAS in Q3 2021 and has held it in 8 quarters since. 654 funds tracked by Wall St. Rank hold EXAS as of Q2 2023.
- Pictet Asset Management (Switzerland) held 61,069 shares of Exact Sciences worth $5.73M as of Q2 2023.
- Pictet Asset Management (Switzerland) bought 1,467 Exact Sciences shares in Q2 2023, an estimated $114K.
- Exact Sciences made up 0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #743 holding.
- Pictet Asset Management (Switzerland) first reported a position in Exact Sciences in Q3 2021 and has held it in 8 quarters since.
- 654 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2023.
Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.